DOCS
Doximity, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "d74f2cf8-b6dd-4df2-9c0e-e1fedd63fef5",
"title": "DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Case By Investing.com",
"description": "DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Case",
"keywords": "",
"snippet": "SAN DIEGO, May 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Doximity, Inc. (NYSE: DOC...",
"url": "https://www.investing.com/news/press-releases/docs-investor-alert-robbins-geller-rudman--dowd-llp-announces-that-doximity-inc-investors-with-substantial-losses-have-opportunity-to-lead-case-93CH-3419833",
"image_url": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
"language": "en",
"published_at": "2024-05-05T18:56:03.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "DOCS",
"name": "Doximity, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 96.18471,
"sentiment_score": -0.094018,
"highlights": [
{
"highlight": "SAN DIEGO, May 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of <em>Doximity</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NYSE</em>: <em>DOCS</em>) common stock between February 9, 2022 and April 1, 2024, both dates inclusive (the Class Period), have until June 17, 2024 to seek appointment as lead plaintiff of the <em>Doximity</em> class action lawsuit. Captioned Kissler v. <em>Doximity</em>, <em>Inc</em>., No. 24-cv-02281 (N.D.",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": ".), the <em>Doximity</em> class action lawsuit charges <em>Doximity</em> as well as certain of Doximity's top executives with violations of the Securities Exchange Act of 1934.",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered substantial losses and wish to serve as lead plaintiff of the <em>Doximity</em> class action lawsuit, please provide your information here:\n\nhttps://www.rgrdlaw.com/cases-<em>doximity</em>-<em>inc</em>-class-action-lawsuit-docs.html\n\nYou can also contact attorneys J.C. Sanchez or Jennifer N.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Lead plaintiff motions for the <em>Doximity</em> class action lawsuit must be filed with the court no later than June 17, 2024.\n\nCASE ALLEGATIONS: <em>Doximity</em> operates a digital platform that provides connections between, medical information to, and patient scheduling tools for medical professionals.",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "conditions on <em>Doximity</em> as well as its reliance on upselling products and services (such as additional advertising) to existing customers to sustain Doximity's performance and future growth.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "See disclosureor\n\nThe <em>Doximity</em> class action lawsuit further alleges that on August 8, 2023, <em>Doximity</em> disclosed that it expected fiscal year 2024 revenue of between $452 million and $468 million (down from prior guidance of between $500 million and $506 million, and representing year-over-year revenue growth of between 7.9% and 11.7%), and adjusted EBITDA",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, the price of <em>Doximity</em> common stock fell nearly 23%, according to the complaint.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, the price of <em>Doximity</em> common stock fell, according to the complaint.\n\nTHE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired <em>Doximity</em> common stock during the Class Period to seek appointment as lead plaintiff in the <em>Doximity</em> class action lawsuit.",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "A lead plaintiff acts on behalf of all other class members in directing the <em>Doximity</em> class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the <em>Doximity</em> class action lawsuit.",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DOCS</em> INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that <em>Doximity</em>, <em>Inc</em>. Investors with Substantial Losses Have Opportunity to Lead Case By Investing.com",
"sentiment": 0.5904,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "DOCS",
"total_documents": 1,
"sentiment_avg": -0.09401799738407135
}
]
}
Other details
Exchange
- New York Stock Exchange
- equity
- Healthcare
- us